Unusual Presentation of Pulmonary Tuberculosis with Massive Haemothorax Leading to Obstructive Shock: A Case Report
Downloads
Introduction : Tuberculosis (TB) remains a major global health burden and continues to pose significant diagnostic challenges due to its nonspecific clinical manifestations. Although pleural effusion is a common extrapulmonary manifestation of TB, massive spontaneous haemothorax leading to obstructive shock is exceedingly rare and potentially life-threatening. Case Description : We report the case of a 56-year-old male who presented with progressive dyspnea and was initially diagnosed with cardiogenic shock and acute decompensated heart failure at a referring hospital. Physical examination revealed hypotension, tachycardia, tachypnea, elevated jugular venous pressure, and decreased breath sounds over the left lung. Imaging demonstrated massive left-sided pleural effusion with mediastinal shift. Bedside transthoracic echocardiography showed preserved biventricular function with significant extrinsic cardiac compression. Emergency chest tube placement evacuated approximately two liters of blood, resulting in rapid hemodynamic improvement, confirming the diagnosis of obstructive shock secondary to massive spontaneous haemothorax. Despite negative molecular testing for tuberculosis from sputum and pleural fluid, chest computed tomography revealed findings highly suggestive of pulmonary tuberculosis. Anti-tuberculosis therapy was initiated, leading to further clinical improvement. The patient was discharged in stable condition after five days of hospitalization. Conclussion : This case underscores pulmonary tuberculosis as a rare etiology of massive spontaneous haemothorax causing obstructive shock. Early recognition of obstructive shock, prompt mechanical decompression, and thorough etiological evaluation are critical for optimal outcomes. In the absence of microbiological confirmation, radiological findings play a pivotal role in establishing a diagnosis of clinically confirmed tuberculosis, and early initiation of anti-tuberculosis therapy may be lifesaving
Copyright (c) 2026 Yudith Megumi Rebhung, Swempi Melchiadi Abolla, Januario E Bria, Charles Saputra

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.






